82 top medical experts on Corpus callosum agenesis neuronopathy across 9 countries and 5 U.S. states, including 7 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Corpus callosum agenesis neuronopathy: Corpus callosum agenesis-neuronopathy syndrome is a neurodegenerative disorder characterized by severe progressive sensorimotor neuropathy beginning in infancy with resulting hypotonia, areflexia, amyotrophy and variable degrees of dysgenesis of the corpus callosum. Additional features include mild-to-severe intellectual and developmental delays, and psychiatric manifestations that include paranoid delusions, depression, hallucinations, and 'autistic-like' features. Affected individuals are usually wheelchair restricted in the second decade of life and die in the third decade of life. The disease is inherited as an autosomal recessive trait.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Support Organizations

Organizations Providing General Support

  • Synonyms: ACCPN,  Agenesis of Corpus Callosum with Neuronopathy,  Agenesis of Corpus Callosum with Peripheral Neuropathy,  Agenesis of Corpus Callosum with Polyneuropathy,  Agenesis of the corpus callosum with peripheral neuropathy,  Andermann syndrome,  Charlevoix disease,  with Neuronopathy Agenesis of Corpus Callosum,  Hereditary Motor and Sensory Neuropathy with Agenesis of the Corpus Callosum,  with or without agenesis of the corpus callosum sensorimotor Polyneuropathy


    •   

            

                        


      Computing Expert Listing ...